Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. Click to read why SBRA is a Buy.

This study uses a Bayesian framework to characterize latent brain state dynamics associated with memory encoding and performance in children, as measured with functional magnetic resonance imaging.

This important study describes long-range serial dependence of performance on a visual texture discrimination training task that manipulated conditions to induce differing degrees of location transfer ...